Company: APM
Filing Date: 2025-12-05
Form Type: 424B5
Source: 0001213900-25-118752
Chunk: 187

Company: Aptorum Group Ltd
Filing Date: 2025-12-05
Form: 424B5
Chunk 187
---
 for (i) violations of RICO 18 U.S.C. § 1962(c), (ii) conspiracy to violate RICO
18 U.S.C. § 1962(d), (iii) fraud; (iv) aiding and abetting breach of fiduciary duty, (v) unjust enrichment, and (vi) civil conspiracy.
Following a motion, Plaintiff was granted leave to amend her Complaint and filed a First Amended Complaint on June 2, 2025. The parties
entered into a briefing schedule on the Company’s anticipated motion to dismiss (“Motion to Dismiss”), and the Company
filed its opening brief on the Motion to Dismiss on July 18, 2025. Plaintiff filed her opposition to the Motion to Dismiss on September
5, 2025, and the Company’s reply in support of the Motion to Dismiss is due on October 6, 2025. The Company continues to believe
that Plaintiff’s claims have no merit. As such, the Company will continue to vigorously defend against Plaintiff’s claims.
At this time, it is too early to estimate the costs and expenses of defending the lawsuit.

Registered Direct Offerings

On October 10, 2025, the Company entered into certain securities purchase
agreement (the “Purchase Agreement”) with certain non-affiliated institutional investors (the “Purchasers”) pursuant
to which the Company agreed to sell (1) 1,000,000 Class A Ordinary Shares pursuant to a registration statement? and (2) in a concurrent
private placement, unregistered warrants to purchase an aggregate of up to 2,000,000 Ordinary Shares (the “Restricted Warrants”),
for aggregate gross proceeds of approximately $2 million (the “October 2025 Offering”).

Each Restricted Warrant is exercisable immediately as of the date of
issuance at an exercise price of $2.00 per Ordinary Share and expires twenty-four months from the effective date of this registration
statement. The Restricted Warrants and the Class A Ordinary Shares issuable upon the exercise of the warrants were not registered under
the Securities Act of 1933, as amended (the “Securities Act”) and were offered pursuant to an exemption from the registration
requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.

The Company agreed in the Purchase Agreement that it would not issue
any Class A Ordinary Shares, or securities convertible or